Immunogenic peptides and their use in transplantation
US9248171B2 · kind B2 · utility
14Cited by
4References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 14, 2008 |
| Grant date | Feb 2, 2016 |
| Priority date | — |
| Expiry date | Feb 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from an allograft antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or treatment of allograft rejection and in the manufacture of medicaments therefore.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.